Dr. Xaralambos B. Zervos, DO

Dr. Zervos practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Zervos' NPI, 1811187925, was assigned on July 26, 2007. Dr. Zervos graduated from Nova Southeastern University - College of Osteopathic Medicine in 2004. Dr. Zervos holds Florida license 10055.

Dr. Zervos' primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Zervos' primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Zervos is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Zervos to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zervos practices, 2 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Zervos' primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Zervos is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Zervos is licensed in Florida.

Dmand AI lists acid reflux, cirrhosis, cirrhosis of the liver, colonoscopy, electrolyte disorders, fatty liver, liver disease and upper GI endoscopy among the conditions Dr. Zervos treats.

CMS data shows 404 Medicare services from Dr. Zervos across 7 procedure codes in 2024, for 208 Medicare patients. Medicare paid $32,620 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Zervos in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zervos' median patient age at 61, with 50% women.

In 2024, Dr. Zervos wrote 660 Medicare Part D claims for 162 patients. 80% of them were for generic drugs. CMS names the drug for 517 of them, across 15 drugs with 11 or more claims each, at $271,833 in total drug cost. In 2023, CMS named 370 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Zervos for performance year 2024, reported through an alternative payment model (APM). Dr. Zervos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zervos as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Zervos, published from 2013 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Liver Transplantation, Antiviral Agents and Hepatitis C. Dr. Zervos has published most often in Transplantation. Dr. Zervos' most frequent co-authors are Nikhil Kapila, MD, Pablo A. Bejarano and Adalberto Jose Gonzalez, MD.

Dmand AI links Dr. Zervos to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Hepatitis, Hepatitis, Alcoholic and Liver Failure, Acute. Vital Therapies, Inc. sponsors the most, 3.

CMS Open Payments shows 76 general payments to Dr. Zervos from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Gilead Sciences, Inc. paid the most, $5,783.

Dr. Zervos graduated from Nova Southeastern University - College of Osteopathic Medicine in 2004.

Dr. Zervos is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.